Adults with respiratory syncytial virus-associated acute respiratory infection (RSV-ARI) are likely to be at a 2.7-fold ...

Respiratory infections, acute or chronic, often have a devastating impact on our health. A recent study has revealed that a ...

A major study presented today at ESCMID Global 2025 has revealed that adults with respiratory syncytial virus-associated acute respiratory infection (RSV-ARI) face a 2.7-fold higher risk of death ...

In recent winters, doctors have warned of a potential “tripledemic”—a surge of three major respiratory illnesses at once. One ...

Australians are preparing for significant numbers of respiratory infections this winter, as cases of influenza, RSV, and ...

A major study presented today at ESCMID Global 2025 has revealed that adults with respiratory syncytial virus-associated acute respiratory infection (RSV-ARI) face a 2.7-fold higher risk of death ...

In 2024, administration of the four FDA-approved RSV vaccinations was low, ranging from 0.27% to 0.58%, according to a poster ...

GlaxoSmithKline (GSK) and Pfizer filed a stipulation to dismiss with prejudice GSK’s litigation in the United States District ...

Flu, RSV, and Covid-19 are still around and getting people sick. However, the number of cases has dropped recently in the ...

Knowledge of respiratory syncytial virus (RSV) disease and RSV vaccine eligibility is low among hospitalized older adults, ...

Acute respiratory syncytial virus was associated with elevated incidence of cardiovascular events among older adults, ...